Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, HealthCare Global Enterprises has informed that, based on the recommendation of the Audit Committee and the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held on December 01, 2025, has approved the appointment of Dr. Manish Mattoo, Executive Director and Chief Executive Officer, as the interim Chief Financial Officer and Key Managerial Personnel of the Company in accordance with Section 203 of the Companies Act, 2013. The appointment shall be effective from December 01, 2025, and shall remain in force until a new Chief Financial Officer is appointed by the Board of Directors and assumes office as the Chief Financial Officer. Details with respect to the above appointment as required under Regulation 30(6) of SEBI LODR Regulations read with the SEBI Master Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (as amended) are enclosed as ‘Annexure - I’. The meeting of the Board of Directors commenced at 2:00 pm (IST) and concluded at 2:55 pm (IST). The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/.
The above information is a part of company’s filings submitted to BSE.
